Form 4 for CNTX Context Therapeutics Inc.
Accepted 2021-10-25 00:00:00 ET · period of report 2021-10-22 · accession 0001179110-21-009608 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-25 | 2021-10-22 | CNTX | Dick Evan G. | SVP of R, D | C - Cnv Deriv | — | +26.6K | 87.1K | +44% | — |
| D | 2021-10-25 | 2021-10-22 | CNTX | Dick Evan G. | SVP of R, D | C - Cnv Deriv | — | -26.6K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-22 | C | A | 26,587 | — | 87,139 | D | — | — | (F1) Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. (F2) Includes 39,659 restricted stock units which fully vest on February 24, 2023. |
| 2 | Derivative | Series Seed Preferred Stock | 2021-10-22 | C | D | 26,587 | — | 0 | D | — · — to — | 26,587 Common Stock | (F1) Each share of Series Seed Preferred Stock had no expiration date and automatically converted into one share of Common Stock upon the closing of the Issuer's initial public offering. (F3) Fully vested. |